by acsmith | May 11, 2024 | News
Galt Pharmaceuticals proudly announces the introduction of Tolectin DS® (Tolmetin Sodium 400mg Capsules), to it’s growing non-opioid pain product portfolio. ATLANTA, GEORGIA, USA, May 9, 2024 /EINPresswire.com/ — Galt Pharmaceuticals, a pioneer in...
by acsmith | Dec 16, 2020 | News
ATLANTA–(BUSINESS WIRE)–Galt Pharmaceuticals announced the acquisition of a specialty branded product from Fortovia Therapeutics. Effective December 2, 2020, Galt added Oravig®, the first and only orally-dissolving buccal tablet for oral thrush, to its growing...
by acsmith | Jan 16, 2020 | News
ATLANTA–(BUSINESS WIRE)–Pharmaceutical innovator Galt Pharmaceuticals announced a new drug approval to offer a non-opioid, non-controlled, non-addictive alternative for healthcare providers to manage patients suffering from pain. On July 8, 2020 the U.S. Food and Drug...
